{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:58:30Z","timestamp":1793703510135,"version":"4.5.1"},"reference-count":187,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"abstract":"<jats:p>Neonatal abstinence syndrome (NAS) is a result of the sudden discontinuation of fetal exposure to substances that were used or abused by the mother during pregnancy. Withdrawal from licit or illicit substances is becoming more common among neonates in both developed and developing countries. NAS continues to be an important clinical entity throughout much of the world. NAS leads to a constellation of signs and symptoms involving multiple systems. The pathophysiology of NAS is not completely understood. Urine or meconium confirmation may assist the diagnosis and management of NAS. The Finnegan scoring system is commonly used to assess the severity of NAS; scoring can be helpful for initiating, monitoring, and terminating treatment in neonates. Nonpharmacological care is the initial treatment option, and pharmacological treatment is required if an improvement is not observed after nonpharmacological measures or if the infant develops severe withdrawal. Morphine is the most commonly used drug in the treatment of NAS secondary to opioids. An algorithmic approach to the management of infants with NAS is suggested. Breastfeeding is not contraindicated in NAS, unless the mother is taking street drugs, is involved in polydrug abuse, or is infected with HIV. Future studies are required to assess the long-term effects of NAS on children after prenatal exposure.<\/jats:p>","DOI":"10.1542\/peds.2013-3524","type":"journal-article","created":{"date-parts":[[2014,7,29]],"date-time":"2014-07-29T00:00:34Z","timestamp":1406592034000},"page":"e547-e561","source":"Crossref","is-referenced-by-count":516,"title":["Neonatal Abstinence Syndrome"],"prefix":"10.1542","volume":"134","author":[{"given":"Prabhakar","family":"Kocherlakota","sequence":"first","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, Maria Fareri Children\u2019s Hospital at New York Medical College, Valhalla, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2014,8,1]]},"reference":[{"key":"2021120903440352700_B1","unstructured":"Heroin timeline. Heroin addiction. Available at: www.heroinaddiction.com\/heroin_timeline.html. Accessed October 12, 2013"},{"issue":"3","key":"2021120903440352700_B2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1360-0443.1975.tb00041.x","article-title":"A social history of heroin addiction.","volume":"70","author":"Merry","year":"1975","journal-title":"Br J Addict Alcohol Other Drugs"},{"key":"2021120903440352700_B3","volume-title":"Dark Paradise: Opiate Addiction in America Before 1940","author":"Courtwright","year":"1982"},{"key":"2021120903440352700_B4","first-page":"182","article-title":"Die morphin kranheit der neugeborenen morphine stischer mutter Monatsschr.","volume":"60","author":"Menninger-Lerchenthal","year":"1934","journal-title":"F Kinderh."},{"key":"2021120903440352700_B5"},{"key":"2021120903440352700_B6","first-page":"2","article-title":"Maternal opium habit and infant mortality.","volume":"3","author":"Earle","year":"1888","journal-title":"M Standard (Chicago)."},{"key":"2021120903440352700_B7","first-page":"1092","article-title":"Fetal morphine addiction, queries and minor notes.","volume":"40","author":"OD","year":"1903","journal-title":"JAMA"},{"issue":"10","key":"2021120903440352700_B8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.1947.62890100006006c","article-title":"Congenital morphinism; a rare cause of convulsions in the newborn.","volume":"135","author":"Perlstein","year":"1947","journal-title":"J Am Med Assoc"},{"issue":"1","key":"2021120903440352700_B9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9378(56)90674-3","article-title":"The effects of maternal narcotic addiction on the newborn.","volume":"71","author":"Goodfriend","year":"1956","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2021120903440352700_B10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1542\/peds.24.2.288","article-title":"The effect of maternal narcotic addiction on the newborn infant; review of literature and report of 22 cases.","volume":"24","author":"Cobrinik","year":"1959","journal-title":"Pediatrics"},{"issue":"22","key":"2021120903440352700_B11","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","article-title":"Effective medical treatment of opiate addiction.","volume":"280","author":"National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"2021120903440352700_B12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1542\/peds.48.3.353","article-title":"Observations on heroin and methadone withdrawal in the newborn.","volume":"48","author":"Reddy","year":"1971","journal-title":"Pediatrics"},{"key":"2021120903440352700_B13","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1080\/10550490490440780","article-title":"French field experience with buprenorphine.","volume":"13","author":"Auriacombe","year":"2004","journal-title":"Am J Addict"},{"key":"2021120903440352700_B14"},{"issue":"5","key":"2021120903440352700_B15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0009-9236(97)90053-9","article-title":"Buprenorphine withdrawal syndrome in a newborn.","volume":"62","author":"Marquet","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"2021120903440352700_B16","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1046\/j.1360-0443.2003.00551.x","article-title":"Buprenorphine withdrawal syndrome in newborns: a report of 13 cases.","volume":"98","author":"Kayemba-Kay\u2019s","year":"2003","journal-title":"Addiction"},{"issue":"4","key":"2021120903440352700_B17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.jp.7210744","article-title":"OxyContin and neonatal abstinence syndrome.","volume":"22","author":"Rao","year":"2002","journal-title":"J Perinatol"},{"issue":"18","key":"2021120903440352700_B18","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"2021120903440352700_B19","article-title":"Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement.","volume":"123","author":"O\u2019Donnell","year":"2009","journal-title":"Pediatrics"},{"key":"2021120903440352700_B20","unstructured":"SAMHSA. Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2011. Available at: www.samhsa.gov\/data\/NSDUH\/2011SummNatFindDetTables\/NSDUH-DetTabsPDFWHTML2011\/2k11DetailedTabs\/Web\/HTML\/NSDUH-DetTabsSect6peTabs55to107-2011.htm#Tab6.72A. Accessed February 25, 2013"},{"issue":"1","key":"2021120903440352700_B21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/GRF.0b013e31827adf91","article-title":"Pharmacologic management of neonatal abstinence syndrome in a community hospital.","volume":"56","author":"Napolitano","year":"2013","journal-title":"Clin Obstet Gynecol"},{"key":"2021120903440352700_B22"},{"issue":"3","key":"2021120903440352700_B23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1479-828X.2009.01008.x","article-title":"Pregnancy and neonatal characteristics of opioid-dependent Indigenous Australians: a rural and metropolitan comparison.","volume":"49","author":"Tetstall","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2021120903440352700_B24","unstructured":"Substance Abuse and Mental Health Administration. Report TEDS. Injection drug abuse admission to substance abuse treatment, 1999 to 2009. Available at: www.samhsa.gov\/data\/2k11\/WEB_TEDS_012\/WEB_TEDS_012.htm. Accessed February 25, 2013"},{"key":"2021120903440352700_B25","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1086\/508184","article-title":"Buprenorphine use: the international experience.","volume":"43","author":"Carrieri","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2021120903440352700_B26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/OGX.0b013e3182788e8c","article-title":"Opioid addiction in pregnancy.","volume":"67","author":"Shainker","year":"2012","journal-title":"Obstet Gynecol Surv"},{"key":"2021120903440352700_B27","first-page":"328","article-title":"Teratology and medications that affect the fetus","volume-title":"Williams Obstetrics","author":"Cunningham","year":"2010","edition":"23rd ed."},{"issue":"1","key":"2021120903440352700_B28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0095-5108(18)30077-0","article-title":"The methadone-maintained pregnancy.","volume":"26","author":"Kandall","year":"1999","journal-title":"Clin Perinatol"},{"issue":"1","key":"2021120903440352700_B29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0889-8545(05)70362-4","article-title":"Opioid dependence during pregnancy. Effects and management.","volume":"25","author":"Kaltenbach","year":"1998","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1","key":"2021120903440352700_B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)21130-2","article-title":"Altered methadone pharmacokinetics in methadone-maintained pregnant women.","volume":"233","author":"Pond","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"2021120903440352700_B31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1300\/J069v18n04_05","article-title":"Alterations in methadone metabolism during late pregnancy.","volume":"18","author":"Jarvis","year":"1999","journal-title":"J Addict Dis"},{"issue":"3","key":"2021120903440352700_B32","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jpeds.2010.03.033","article-title":"Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome.","volume":"157","author":"Seligman","year":"2010","journal-title":"J Pediatr"},{"key":"2021120903440352700_B33"},{"issue":"3","key":"2021120903440352700_B34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jsat.2010.11.007","article-title":"Higher maternal doses of methadone does not increase neonatal abstinence syndrome.","volume":"40","author":"Pizarro","year":"2011","journal-title":"J Subst Abuse Treat"},{"key":"2021120903440352700_B35"},{"issue":"3 pt 1","key":"2021120903440352700_B36","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ajog.2005.03.072","article-title":"High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes.","volume":"193","author":"McCarthy","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"2021120903440352700_B37","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1360-0443.2010.03120.x","article-title":"Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis.","volume":"105","author":"Cleary","year":"2010","journal-title":"Addiction"},{"key":"2021120903440352700_B38"},{"issue":"8","key":"2021120903440352700_B39","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40263-013-0072-z","article-title":"Buprenorphine use in pregnant opioid users: a critical review.","volume":"27","author":"Soyka","year":"2013","journal-title":"CNS Drugs"},{"key":"2021120903440352700_B40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"issue":"1","key":"2021120903440352700_B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":"Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.","volume":"79","author":"Jones","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"2021120903440352700_B42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","article-title":"Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution.","volume":"82","author":"Lejeune","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2021120903440352700_B43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2006.01321.x","article-title":"Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study.","volume":"101","author":"Fischer","year":"2006","journal-title":"Addiction"},{"issue":"1-2","key":"2021120903440352700_B44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugalcdep.2008.01.025","article-title":"Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.","volume":"96","author":"Kakko","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"2021120903440352700_B45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000210042","article-title":"Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.","volume":"15","author":"Bakstad","year":"2009","journal-title":"Eur Addict Res"},{"key":"2021120903440352700_B46","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00228-011-1049-9","article-title":"Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.","volume":"67","author":"Lacroix","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"issue":"1-3","key":"2021120903440352700_B47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2012.07.001","article-title":"Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.","volume":"127","author":"Welle-Strand","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"2021120903440352700_B48","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/jpc.12264","article-title":"Perinatal outcomes of Australian buprenorphine-exposed mothers and their newborn infants.","volume":"49","author":"Patel","year":"2013","journal-title":"J Paediatr Child Health"},{"issue":"24","key":"2021120903440352700_B49","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure.","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"2021120903440352700_B50","first-page":"CD006318","article-title":"Maintenance agonist treatments for opiate-dependent pregnant women.","volume":"12","author":"Minozzi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2021120903440352700_B51","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.drugalcdep.2013.11.006","article-title":"Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy.","volume":"134","author":"Jones","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"2021120903440352700_B52","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.annepidem.2013.05.017","article-title":"Increasing pregnancy-related use of prescribed opioid analgesics.","volume":"23","author":"Epstein","year":"2013","journal-title":"Ann Epidemiol"},{"issue":"3","key":"2021120903440352700_B53","first-page":"241","article-title":"The prevalence of prenatal opioid and other drug use in Utah.","volume":"30","author":"Buchi","year":"2013","journal-title":"Am J Perinatol"},{"issue":"9","key":"2021120903440352700_B54","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00228-011-1030-7","article-title":"Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study.","volume":"67","author":"Handal","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2021120903440352700_B55","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00006250-201210000-00044","article-title":"Committee opinion no. 538: nonmedical use of prescription drugs.","volume":"120","author":"Committee on Health Care for Underserved Women, The American College of Obstetricians and Gynecologists","year":"2012","journal-title":"Obstet Gynecol"},{"key":"2021120903440352700_B56"},{"issue":"11","key":"2021120903440352700_B57","first-page":"e441","article-title":"Narcotic-exposed neonates in a First Nations population in northwestern Ontario: incidence and implications.","volume":"57","author":"Kelly","year":"2011","journal-title":"Can Fam Physician"},{"key":"2021120903440352700_B58"},{"key":"2021120903440352700_B59"},{"key":"2021120903440352700_B60"},{"issue":"4","key":"2021120903440352700_B61","first-page":"1001","article-title":"ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation.","volume":"111","author":"ACOG Committee on Practice Bulletins","year":"2008","journal-title":"Obstet Gynecol"},{"key":"2021120903440352700_B62"},{"issue":"1","key":"2021120903440352700_B63","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2012.153812","article-title":"Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.","volume":"309","author":"Stephansson","year":"2013","journal-title":"JAMA"},{"key":"2021120903440352700_B64","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2147\/NDT.S36394","article-title":"The use of psychotropic medication during pregnancy: how about the newborn?","volume":"9","author":"Kieviet","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2021120903440352700_B65","unstructured":"Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. Results from the 2012 National Survey on Drug Use and Health: summary of national findings. Available at: www.samhsa.gov\/data\/NSDUH\/2012SummNatFindDetTables\/NationalFindings\/NSDUHresults2012.pdf. Accessed January 14, 2014"},{"key":"2021120903440352700_B66","unstructured":"United Nations Office on Drugs and Crime. Global smart update 2012. Volume 8. Available at: www.unodc.org\/documents\/scientific\/Global_SMART_Update_8_E_web.pdf. Accessed January 24, 2014"},{"issue":"10","key":"2021120903440352700_B67","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/jp.2012.59","article-title":"Amphetamines, the pregnant woman and her children: a review.","volume":"32","author":"Oei","year":"2012","journal-title":"J Perinatol"},{"issue":"1","key":"2021120903440352700_B68","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0889-8545(05)70363-6","article-title":"Inhalant abuse in pregnancy.","volume":"25","author":"Jones","year":"1998","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2021120903440352700_B69"},{"issue":"3","key":"2021120903440352700_B70","doi-asserted-by":"crossref","first-page":"F204","DOI":"10.1136\/fn.74.3.F204","article-title":"Neonatal withdrawal from maternal volatile substance abuse.","volume":"74","author":"Tenenbein","year":"1996","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2021120903440352700_B71"},{"issue":"2","key":"2021120903440352700_B72","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00003081-199306000-00006","article-title":"Kinetics of drug transfer to the fetus.","volume":"36","author":"Szeto","year":"1993","journal-title":"Clin Obstet Gynecol"},{"key":"2021120903440352700_B73","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1477-7827-7-61","article-title":"The impact of cocaine and heroin on the placental transfer of methadone.","volume":"7","author":"Malek","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"2021120903440352700_B74","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3476(99)70163-0","article-title":"Morphine pharmacokinetics and pain assessment in premature newborns.","volume":"135","author":"Scott","year":"1999","journal-title":"J Pediatr"},{"issue":"2","key":"2021120903440352700_B75","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/138945012799201612","article-title":"Current research on opioid receptor function.","volume":"13","author":"Feng","year":"2012","journal-title":"Curr Drug Targets"},{"key":"2021120903440352700_B76","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/ilar.52.3.329","article-title":"Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience.","volume":"52","author":"Barr","year":"2011","journal-title":"ILAR J"},{"issue":"1","key":"2021120903440352700_B77","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/1871527311312010017","article-title":"Opioid withdrawal syndrome: emerging concepts and novel therapeutic targets.","volume":"12","author":"Rehni","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2021120903440352700_B78","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuroscience.2013.04.034","article-title":"Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.","volume":"248","author":"Scavone","year":"2013","journal-title":"Neuroscience"},{"issue":"1","key":"2021120903440352700_B79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0376-8716(96)01236-7","article-title":"Role of noradrenergic hyperactivity in neonatal opiate abstinence.","volume":"41","author":"Little","year":"1996","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"2021120903440352700_B80","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1111\/j.1460-9568.2005.04416.x","article-title":"Morphine withdrawal-induced morphological changes in the nucleus accumbens.","volume":"22","author":"Spiga","year":"2005","journal-title":"Eur J Neurosci"},{"issue":"20","key":"2021120903440352700_B81","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1523\/JNEUROSCI.0172-11.2011","article-title":"An anatomical basis for opponent process mechanisms of opiate withdrawal.","volume":"31","author":"Radke","year":"2011","journal-title":"J Neurosci"},{"issue":"3","key":"2021120903440352700_B82","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","article-title":"Opioid receptors: distinct roles in mood disorders.","volume":"36","author":"Lutz","year":"2013","journal-title":"Trends Neurosci"},{"key":"2021120903440352700_B83"},{"key":"2021120903440352700_B84","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/1874091X00903010078","article-title":"Molecules acting on CB1 receptor and their effects on morphine withdrawal in vitro.","volume":"3","author":"Capasso","year":"2009","journal-title":"Open Biochem J"},{"issue":"4","key":"2021120903440352700_B85","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1471-4159.2006.04421.x","article-title":"Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal.","volume":"101","author":"Nunez","year":"2007","journal-title":"J Neurochem"},{"issue":"1","key":"2021120903440352700_B86","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jopan.2011.11.002","article-title":"Opioid-induced hyperalgesia.","volume":"27","author":"Pasero","year":"2012","journal-title":"J Perianesth Nurs"},{"issue":"4","key":"2021120903440352700_B87","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1203\/PDR.0b013e31820bd165","article-title":"Effects of neonatal stress and morphine on murine hippocampal gene expression.","volume":"69","author":"Juul","year":"2011","journal-title":"Pediatr Res"},{"issue":"6","key":"2021120903440352700_B88","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0022-3476(05)82214-0","article-title":"Neonatal opiate abstinence syndrome in term and preterm infants.","volume":"118","author":"Doberczak","year":"1991","journal-title":"J Pediatr"},{"issue":"5","key":"2021120903440352700_B89","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/bja\/aen248","article-title":"Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial.","volume":"101","author":"Anand","year":"2008","journal-title":"Br J Anaesth"},{"issue":"4","key":"2021120903440352700_B90","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1515\/JPM.2007.063","article-title":"Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome.","volume":"35","author":"Dysart","year":"2007","journal-title":"J Perinat Med"},{"issue":"9458","key":"2021120903440352700_B91","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(05)17865-9","article-title":"Selective serotonin inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis.","volume":"365","author":"Sanj","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"2021120903440352700_B92","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/1874473711205030227","article-title":"Mechanism of action of methamphetamine within the catecholamine and serotonin areas of the central nervous system.","volume":"5","author":"Chiu","year":"2012","journal-title":"Curr Drug Abuse Rev"},{"key":"2021120903440352700_B93","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1360-0443.2012.04039.x","article-title":"Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.","volume":"107","author":"Gaalema","year":"2012","journal-title":"Addiction"},{"issue":"4","key":"2021120903440352700_B94","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-3476(77)80523-4","article-title":"Neonatal seizures associated with narcotic withdrawal.","volume":"91","author":"Herzlinger","year":"1977","journal-title":"J Pediatr"},{"issue":"1-3","key":"2021120903440352700_B95","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.drugalcdep.2010.01.004","article-title":"Infant autonomic functioning and neonatal abstinence syndrome.","volume":"109","author":"Jansson","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2021120903440352700_B96","article-title":"Neonatal drug withdrawal.","volume":"129","author":"American Academy of Pediatrics Clinical Report","year":"2012","journal-title":"Pediatrics"},{"key":"2021120903440352700_B97"},{"issue":"3","key":"2021120903440352700_B98","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1479-828X.2010.01168.x","article-title":"Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.","volume":"50","author":"Liu","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5","key":"2021120903440352700_B99","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1471-0528.2008.02073.x","article-title":"Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.","volume":"116","author":"Dryden","year":"2009","journal-title":"BJOG"},{"issue":"6","key":"2021120903440352700_B100","doi-asserted-by":"crossref","first-page":"F472","DOI":"10.1136\/archdischild-2011-214239","article-title":"Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.","volume":"97","author":"Sie","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"2021120903440352700_B101","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s13181-012-0228-0","article-title":"Stimulant methamphetamine and dextromethorphan use among Thai adolescents: implications for health of women and children.","volume":"8","author":"Chomchai","year":"2012","journal-title":"J Med Toxicol"},{"issue":"1","key":"2021120903440352700_B102","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.drugalcdep.2013.06.004","article-title":"Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone.","volume":"133","author":"Gaalema","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20132","key":"2021120903440352700_B103","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1440-1754.2007.00994.x","article-title":"Management of the newborn infant affected by maternal opiates and other drugs of dependency.","volume":"43","author":"Oei","year":"2007","journal-title":"J Paediatr Child Health"},{"issue":"8","key":"2021120903440352700_B104","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1360-0443.2012.03844.x","article-title":"Methadone and perinatal outcomes: a prospective cohort study.","volume":"107","author":"Cleary","year":"2012","journal-title":"Addiction"},{"issue":"17","key":"2021120903440352700_B105","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2013.3411","article-title":"Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome.","volume":"309","author":"Wachman","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"2021120903440352700_B106","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2011.10.003","article-title":"Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes.","volume":"122","author":"Jansson","year":"2012","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"2021120903440352700_B107","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1360-0443.2003.00391.x","article-title":"Maternal drug use and length of neonatal unit stay.","volume":"98","author":"Johnson","year":"2003","journal-title":"Addiction"},{"issue":"5","key":"2021120903440352700_B108","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1055\/s-0033-1349096","article-title":"Treatment of neonatal abstinence syndrome in preterm and term neonates.","volume":"225","author":"Dabek","year":"2013","journal-title":"Klin Padiatr"},{"key":"2021120903440352700_B109","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1360-0443.2012.04038.x","article-title":"Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.","volume":"107","author":"Kaltenbach","year":"2012","journal-title":"Addiction"},{"issue":"1","key":"2021120903440352700_B110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10550887.2011.642765","article-title":"Substance use during pregnancy and postnatal outcomes.","volume":"31","author":"Irner","year":"2012","journal-title":"J Addict Dis"},{"key":"2021120903440352700_B111"},{"issue":"5","key":"2021120903440352700_B112","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1515\/jpm-2012-0288","article-title":"Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy?","volume":"41","author":"O\u2019Connor","year":"2013","journal-title":"J Perinat Med"},{"issue":"6","key":"2021120903440352700_B113","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.genm.2011.10.001","article-title":"Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates?","volume":"8","author":"Unger","year":"2011","journal-title":"Gend Med"},{"issue":"3","key":"2021120903440352700_B114","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugalcdep.2012.11.019","article-title":"Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes.","volume":"131","author":"Jones","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"2021120903440352700_B115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/ADM.0b013e3182266a3a","article-title":"The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome.","volume":"5","author":"Wachman","year":"2011","journal-title":"J Addict Med"},{"issue":"3","key":"2021120903440352700_B116","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cll.2012.06.008","article-title":"Drug testing in the neonate.","volume":"32","author":"Cotten","year":"2012","journal-title":"Clin Lab Med"},{"issue":"3","key":"2021120903440352700_B117","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1067\/mpd.2001.111429","article-title":"Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis.","volume":"138","author":"Ostrea","year":"2001","journal-title":"J Pediatr"},{"issue":"6","key":"2021120903440352700_B118","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/FTD.0b013e31815c14ce","article-title":"Biological matrices for the evaluation of in utero exposure to drugs of abuse.","volume":"29","author":"Lozano","year":"2007","journal-title":"Ther Drug Monit"},{"key":"2021120903440352700_B119"},{"issue":"9","key":"2021120903440352700_B120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.clinbiochem.2012.02.029","article-title":"Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay.","volume":"45","author":"Cotten","year":"2012","journal-title":"Clin Biochem"},{"issue":"8","key":"2021120903440352700_B121","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/15563650.2012.713108","article-title":"Role of liquid chromatography-high-resolution mass spectrometry (LC-HR\/MS) in clinical toxicology.","volume":"50","author":"Wu","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"2021120903440352700_B122","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/1556-4029.12306","article-title":"Designer psychostimulants in urine by liquid chromatography-tandem mass spectrometry.","volume":"59","author":"Kerrigan","year":"2014","journal-title":"J Forensic Sci"},{"issue":"3","key":"2021120903440352700_B123","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cll.2012.06.003","article-title":"Alcohol biomarkers.","volume":"32","author":"Ingall","year":"2012","journal-title":"Clin Lab Med"},{"issue":"4","key":"2021120903440352700_B124","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/JPN.0b013e3181fa13ea","article-title":"Identifying infants at risk for neonatal abstinence syndrome: a retrospective cohort comparison study of 3 screening approaches.","volume":"24","author":"Murphy-Oikonen","year":"2010","journal-title":"J Perinat Neonatal Nurs"},{"issue":"8","key":"2021120903440352700_B125","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1651-2227.2008.00838.x","article-title":"Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero.","volume":"97","author":"Hytinantti","year":"2008","journal-title":"Acta Paediatr"},{"issue":"1\u20132","key":"2021120903440352700_B126","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management.","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"issue":"4","key":"2021120903440352700_B127","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1542\/hpeds.2012-0079","article-title":"Neonatal abstinence syndrome management from prenatal counseling to a post discharge follow-up care: results of a national survey.","volume":"3","author":"Mehta","year":"2013","journal-title":"Hosp Pediatr"},{"issue":"6","key":"2021120903440352700_B128","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/ANC.0000000000000033","article-title":"Validation of the Finnegan Neonatal Abstinence Syndrome Tool-short form.","volume":"13","author":"Maguire","year":"2013","journal-title":"Adv Neonatal Care"},{"issue":"2","key":"2021120903440352700_B129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004703-199804000-00005","article-title":"The neonatal withdrawal inventory: a simplified score of newborn withdrawal.","volume":"19","author":"Zahorodny","year":"1998","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"2021120903440352700_B130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.jp.7211427","article-title":"Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey.","volume":"26","author":"Sarkar","year":"2006","journal-title":"J Perinatol"},{"issue":"4","key":"2021120903440352700_B131","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2006-2083","article-title":"Swaddling: a systematic review.","volume":"120","author":"van Sleuwen","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"2021120903440352700_B132","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpeds.2006.12.029","article-title":"Swaddling young infants can decrease crying time.","volume":"150","author":"Caiola","year":"2007","journal-title":"J Pediatr"},{"issue":"3","key":"2021120903440352700_B133","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00005721-199905000-00007","article-title":"Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants.","volume":"24","author":"D\u2019Apolito","year":"1999","journal-title":"MCN Am J Matern Child Nurs"},{"key":"2021120903440352700_B134","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1542\/peds.101.6.1079","article-title":"Neonatal drug withdrawal.","volume":"101(6)","author":"American Academy of Pediatrics Committee on Drugs","year":"1998","journal-title":"Pediatrics"},{"issue":"4","key":"2021120903440352700_B135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7453\/gahmj.2012.1.4.007","article-title":"Non-insertive acupuncture and neonatal abstinence syndrome: a case series from an inner city safety net hospital.","volume":"1","author":"Filippelli","year":"2012","journal-title":"Glob Adv Health Med"},{"issue":"5","key":"2021120903440352700_B136","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0033-1347190","article-title":"Neonatal opiate withdrawal and rooming in: a retrospective analysis of a single center experience.","volume":"225","author":"Hunseler","year":"2013","journal-title":"Klin Padiatr."},{"issue":"5","key":"2021120903440352700_B137","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1701-2163(16)35245-8","article-title":"A rooming-in program to mitigate the need to treat for opiate withdrawal in the newborn.","volume":"34","author":"Hodgson","year":"2012","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"2021120903440352700_B138","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.siny.2007.01.004","article-title":"Managing drug withdrawal in the newborn infant.","volume":"12","author":"Kuschel","year":"2007","journal-title":"Semin Fetal Neonatal Med"},{"issue":"4","key":"2021120903440352700_B139","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00404-012-2372-9","article-title":"Maternal and neonatal outcomes following methadone substitution during pregnancy.","volume":"286","author":"Greig","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"2021120903440352700_B140"},{"issue":"5","key":"2021120903440352700_B141","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.pcl.2012.07.006","article-title":"Pharmacologic management of the opioid neonatal abstinence syndrome.","volume":"59","author":"Kraft","year":"2012","journal-title":"Pediatr Clin North Am"},{"issue":"2","key":"2021120903440352700_B142","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/NMC.0b013e31826e978e","article-title":"Neonatal abstinence syndrome: therapeutic interventions.","volume":"38","author":"Sublett","year":"2013","journal-title":"MCN Am J Matern Child Nurs"},{"issue":"3","key":"2021120903440352700_B143","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clp.2013.05.004","article-title":"Management of neonatal abstinence syndrome from opioids.","volume":"40","author":"Grim","year":"2013","journal-title":"Clin Perinatol"},{"issue":"10","key":"2021120903440352700_B144","first-page":"CD002053","article-title":"Sedatives for opiate withdrawal in newborn infants.","author":"Osborn","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2021120903440352700_B145","doi-asserted-by":"crossref","first-page":"F249","DOI":"10.1136\/adc.2008.152769","article-title":"Management of neonatal abstinence syndrome: a national survey and review of practice.","volume":"94","author":"O\u2019Grady","year":"2009","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"2021120903440352700_B146","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2009.0006","article-title":"The opioid-exposed newborn: assessment and pharmacologic management.","volume":"5","author":"Jansson","year":"2009","journal-title":"J Opioid Manag"},{"issue":"6","key":"2021120903440352700_B147","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/jp.2011.114","article-title":"Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting.","volume":"32","author":"Backes","year":"2012","journal-title":"J Perinatol"},{"issue":"2","key":"2021120903440352700_B148","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/ADM.0b013e318280f495","article-title":"Stability of dilute oral morphine solution for neonatal abstinence syndrome.","volume":"7","author":"Sauberan","year":"2013","journal-title":"J Addict Med"},{"issue":"4","key":"2021120903440352700_B149","doi-asserted-by":"crossref","first-page":"F300","DOI":"10.1136\/adc.2003.033555","article-title":"A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome.","volume":"89","author":"Jackson","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"11","key":"2021120903440352700_B150","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/jp.2011.116","article-title":"Update on the pharmacologic management of neonatal abstinence syndrome.","volume":"31","author":"Bio","year":"2011","journal-title":"J Perinatol"},{"issue":"4","key":"2021120903440352700_B151","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/10408363.2011.620601","article-title":"Methadone: a review of drug-drug and pathophysiological interactions.","volume":"48","author":"Kapur","year":"2011","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"3","key":"2021120903440352700_B152","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1360-0443.2010.03170.x","article-title":"Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome.","volume":"106","author":"Kraft","year":"2011","journal-title":"Addiction"},{"issue":"6","key":"2021120903440352700_B153","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/15563650902980019","article-title":"Use of clonidine in the prevention and management of neonatal abstinence syndrome.","volume":"47","author":"Leikin","year":"2009","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"2021120903440352700_B154","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1651-2227.2009.01547.x","article-title":"Treatment of neonatal abstinence syndrome with clonidine and chloral hydrate.","volume":"99","author":"Esmaeili","year":"2010","journal-title":"Acta Paediatr"},{"issue":"5","key":"2021120903440352700_B155","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2008-0978","article-title":"Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.","volume":"123","author":"Agthe","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"2021120903440352700_B156","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"Transfer of drugs and other chemicals into human milk.","volume":"108","author":"American Academy of Pediatrics Committee on Drugs","year":"2001","journal-title":"Pediatrics"},{"issue":"3","key":"2021120903440352700_B157","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-1985","article-title":"Committee on Drugs. The transfer of drugs and therapeutics into human breast milk: an update on selected topics.","volume":"132","author":"Sachs","year":"2013","journal-title":"Pediatrics"},{"issue":"1","key":"2021120903440352700_B158","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1542\/peds.2007-1182","article-title":"Methadone maintenance and breastfeeding in the neonatal period.","volume":"121","author":"Jansson","year":"2008","journal-title":"Pediatrics"},{"issue":"2","key":"2021120903440352700_B159","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/089033440001600206","article-title":"Methadone levels in human milk.","volume":"16","author":"McCarthy","year":"2000","journal-title":"J Hum Lact"},{"key":"2021120903440352700_B160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/bfm.2011.0096","article-title":"Estimated dose exposure of the neonate to buprenorphine and its metabolite norbuprenorphine via breastmilk during maternal buprenorphine substitution treatment.","volume":"7","author":"Ilett","year":"2012","journal-title":"Breastfeed Med"},{"issue":"5","key":"2021120903440352700_B161","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","article-title":"ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy.","volume":"119","author":"ACOG Committee on Health Care for Underserved Women","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2021120903440352700_B162","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/bfm.2009.9987","article-title":"ABM clinical protocol #21: Guidelines for breastfeeding and the drug-dependent woman.","volume":"4","author":"Jansson","year":"2009","journal-title":"Breastfeed Med"},{"issue":"4","key":"2021120903440352700_B163","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/jmwh.12009","article-title":"Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.","volume":"58","author":"O\u2019Connor","year":"2013","journal-title":"J Midwifery Womens Health"},{"issue":"6","key":"2021120903440352700_B164","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/bfm.2010.0060","article-title":"Estimated infant exposure to enantiomer-specific methadone levels in breastmilk.","volume":"6","author":"Bogen","year":"2011","journal-title":"Breastfeed Med"},{"issue":"2","key":"2021120903440352700_B165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0890334408328295","article-title":"Transfer of buprenorphine into breast milk and calculation of infant drug dose.","volume":"25","author":"Lindemalm","year":"2009","journal-title":"J Hum Lact"},{"issue":"1","key":"2021120903440352700_B166","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/jp.2010.66","article-title":"Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome.","volume":"31","author":"Isemann","year":"2011","journal-title":"J Perinatol"},{"issue":"3","key":"2021120903440352700_B167","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/AOG.0b013e31820ca504","article-title":"Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum pain.","volume":"117","author":"Sauberan","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2021120903440352700_B168","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1479-828X.2007.00715.x","article-title":"Oxycodone as a component of multimodal analgesia for lactating mothers after Caesarean section: relationships between maternal plasma, breast milk and neonatal plasma levels.","volume":"47","author":"Seaton","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"6","key":"2021120903440352700_B169","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2174\/138920012800840392","article-title":"Pharmacogenetics of opioids for the treatment of acute maternal pain during pregnancy and lactation.","volume":"13","author":"Madadi","year":"2012","journal-title":"Curr Drug Metab"},{"issue":"11","key":"2021120903440352700_B170","first-page":"1060","article-title":"Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants.","volume":"102","author":"Welle-Strand","year":"2013","journal-title":"Acta Paediatr"},{"issue":"6","key":"2021120903440352700_B171","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2005-1561","article-title":"Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers.","volume":"117","author":"Abdel-Latif","year":"2006","journal-title":"Pediatrics"},{"key":"2021120903440352700_B172"},{"issue":"4","key":"2021120903440352700_B173","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jpeds.2013.04.033","article-title":"Prenatal substance exposure: neurobiological organization at 1 month.","volume":"163","author":"Conradt","year":"2013","journal-title":"J Pediatr."},{"issue":"1","key":"2021120903440352700_B174","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.earlhumdev.2007.01.013","article-title":"Adverse neurodevelopmental outcome of infants exposed to opiate in-utero.","volume":"84","author":"Hunt","year":"2008","journal-title":"Early Hum Dev"},{"issue":"2","key":"2021120903440352700_B175","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/10550881003684921","article-title":"Children of addicted women.","volume":"29","author":"Lester","year":"2010","journal-title":"J Addict Dis"},{"issue":"12","key":"2021120903440352700_B176","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/syn.20694","article-title":"Prenatal morphine exposure alters the layer II\/III pyramidal neurons morphology in lateral secondary visual cortex of juvenile rats.","volume":"63","author":"Mei","year":"2009","journal-title":"Synapse"},{"issue":"1","key":"2021120903440352700_B177","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/toxsci\/kfs234","article-title":"Effects of morphine on the differentiation and survival of developing pyramidal neurons during the brain growth spurt.","volume":"130","author":"Massa","year":"2012","journal-title":"Toxicol Sci"},{"issue":"1","key":"2021120903440352700_B178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2012.04.008","article-title":"Neural tract development of infants born to methadone-maintained mothers.","volume":"47","author":"Walhovd","year":"2012","journal-title":"Pediatr Neurol"},{"issue":"4","key":"2021120903440352700_B179","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.neuroimage.2007.03.070","article-title":"Volumetric cerebral characteristics of children exposed to opiates and other substances in utero.","volume":"36","author":"Walhovd","year":"2007","journal-title":"Neuroimage"},{"issue":"7","key":"2021120903440352700_B180","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/da.20706","article-title":"Neurodevelopmental effects of prenatal exposure to psychotropic medications.","volume":"27","author":"Gentile","year":"2010","journal-title":"Depress Anxiety"},{"issue":"25","key":"2021120903440352700_B181","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1301449","article-title":"Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.","volume":"369","author":"Hviid","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"2021120903440352700_B182","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ntt.2010.10.004","article-title":"Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine.","volume":"33","author":"Smith","year":"2011","journal-title":"Neurotoxicol Teratol"},{"key":"2021120903440352700_B183","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.ajog.2012.10.293","article-title":"Opiate abuse\/usage in pregnancy and newborn head circumference.","volume":"208","author":"Visconti","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2021120903440352700_B184","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/apa.12210","article-title":"Neurobehavioural development of preschool-age children born to addicted mothers given opiate maintenance treatment with buprenorphine during pregnancy.","volume":"102","author":"Sundelin Wahlsten","year":"2013","journal-title":"Acta Paediatr"},{"issue":"3","key":"2021120903440352700_B185","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1651-2227.2003.tb00561.x","article-title":"Strabismus in infants of opiate-dependent mothers.","volume":"92","author":"Gill","year":"2003","journal-title":"Acta Paediatr"},{"issue":"1","key":"2021120903440352700_B186","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ajo.2013.02.004","article-title":"The short- and long-term effects on the visual system of children following exposure to maternal substance misuse in pregnancy.","volume":"156","author":"Spiteri Cornish","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"2021120903440352700_B187","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2012-2113","article-title":"Neonatal visual evoked potentials in infants born to mothers prescribed methadone.","volume":"131","author":"McGlone","year":"2013","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/2\/e547\/1103811\/peds_2013-3524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/2\/e547\/1103811\/peds_2013-3524.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T19:48:53Z","timestamp":1746301733000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/134\/2\/e547\/32952\/Neonatal-Abstinence-Syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":187,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,8,1]]},"published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2013-3524","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,1]]}}}